Adeno-Associated Virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
AssigneeThe Trustees of the University of Pennsylvania
InventorsGuangping Gao, James Wilson, Mauricio Alvira
Life of this patent
Estimating the term…
Abstract
Sequences of a serotype 8 adeno-associated virus and vectors and host cells containing these sequences are provided. Also described are methods of using such host cells and vectors in production of rAAV particles. rAAV8-mediated delivery of therapeutic and immunogenic genes, including Factor VIII, is also provided.
Claims18
A method of inducing an immune response to an HIV antigen, said method comprising delivering an adeno-associated virus (AAV) vector comprising an AAV8 capsid protein having an amino acid sequence of amino acids 1 to 737 of SEQ ID NO:2 or a sequence which is at least 95% identical therewith,
- and a transgene encoding a product under control of regulatory elements that direct expression of the product to a subject, wherein said product is selected from the group consisting of HIV antigens and simian immune deficiency antigens.
An immunogenic regimen comprising delivery of an adeno-associated virus (AAV) vector comprising an AAV8 capsid protein having an amino acid sequence of amino acids 1 to 737 of SEQ ID NO:2 or a sequence which is at least 95% identical therewith,
- and a transgene encoding a product under control of regulatory elements that direct expression of the product in a host cell, wherein said product is an immunogen.
A host cell containing a molecule comprising an adeno-associated 8 (AAV8) nucleic acid capsid sequence selected from the group consisting of:
- vp1, nt 2121 to 4335;
- vp2, nt 2532 to 4335;
- and
- vp3, nt 2730 to 4335, wherein the nucleotides numbers are of AAV8, SEQ ID NO:1
- and a heterologous nucleic acid sequence comprising a functional AAV rep protein
An adeno-associated virus capsid protein comprising one or more fragments of an AAV8 capsid protein fused to a heterologous protein, wherein said one or more fragments of an AAV8 capsid protein are selected from the group consisting of:
- a fragment of an AAV8 encompassing hypervariable region (HVR)1 through 12 selected the group consisting of:
- aa 146 to 152;
- aa 182 to 187;
- aa 262 to 264;
- aa 263 to 266;
- aa 381 to 383;
- aa 383 to 385;
- aa 450 to 474;
- aa 451 to 475;
- aa 490 to 495;
- aa 491 to 496;
- aa500 to 504;
- aa 501 to 505;
- aa 514 to 522;
- aa 533 to 554;
- aa 534 to 555;
- aa 581 to 594;
- aa 583 to 596;
- aa 658 to 667;
- aa 660 to 669;
- aa 705 to 719;
- aa 707 to 723;
- aa 24 to 42, aa 25 to 28;
- aa 81 to 85;
- aa 133 to 165;
- aa 134 to 165;
- aa 137 to 143;
- aa 154 to 156;
- aa 194 to 208;
- aa 261 to 274;
- aa 262 to 274;
- aa 171 to 173;
- aa 185 to 198;
- aa 413 to 417;
- aa 449 to 478;
- aa 494 to 525;
- aa 534 to 571;
- aa 581 to 601;
- aa 660 to 671;
- aa 709 to 723;
- and
- aa 1 to 184, aa 199 to 259;
- aa 274 to 446;
- aa 603 to 659;
- aa 670 to 706;
- aa 724 to 736;
- aa 185 to 198;
- aa 260 to 273;
- aa447 to 477;
- aa495 to 602;
- aa603 to 659;
- aa 660 to 669;
- and aa707 to 723, wherein the amino acid numbers are those of the AAV2 capsid, SEQ ID NO:4 and corresponding regions in the capsid of AAV8, SEQ ID NO:2.
An isolated AAV8 nucleic acid sequence selected from the group consisting of:
- vp1, nt 2121 to 4335;
- vp2, nt 2532 to 4335;
- and
- vp 3, nt 2730 to 4335,
- wherein the nucleotides numbers are of AAV8, SEQ ID NO:1.
An isolated nucleic acid molecule encoding adeno-associated virus 8 (AAV8), said molecule having the nucleic acid sequence of SEQ ID NO:
- 1 or a sequence which is at least 95% identical therewith.
Dependencies are inferred from the claim text.